Microbial Keratitis in Cairo University Hospitals

NCT ID: NCT05387993

Last Updated: 2022-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

85 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-10

Study Completion Date

2021-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study was to identify the incidence of infective keratitis presenting to the ophthalmology emergency department at Cairo University hospital, the risk factors and the bacterial/fungal spectrum causing the ulcers and to determine the best possible empirical therapy followed by specific therapy after obtaining culture results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infective Keratitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients presenting at the casualty who are clinically diagnosed as infectious keratitis , of all age groups and including both genders.

Exclusion Criteria

Patients presenting with clinical picture suggestive of

* Viral keratitis solely without superimposed secondary infection.
* Non infectious keratitis as peripheral ulcerative keratitis ( e.g. Mooren's ulcer, marginal keratitis, autoimmune keratitis )
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nevien Lotfy Abdelkader

Ophthalmology Resident at the Ophthalmology Department, Cairo University.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yehia Mostafa, MD

Role: STUDY_CHAIR

Kasr Al Aini Hospital

Mohamed El Agha, MD

Role: STUDY_DIRECTOR

Kasr Al Aini Hospital

Ihab Othman, MD

Role: STUDY_DIRECTOR

Kasr Al Aini Hospital

Moushira Hosny, MD

Role: STUDY_DIRECTOR

Kasr Al Aini Hospital

Nevien Lotfy, MSc

Role: PRINCIPAL_INVESTIGATOR

Kasr Al Aini Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Al Aini Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS-427-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OCT-A and Amblyopia
NCT05223153 COMPLETED
Magnet for Corneal Foreign Bodies
NCT03778190 COMPLETED NA